Among the substitute GLP-1 receptor agonists are: Albiglutide (Tanzeum) Exenatide (Bydureon, Byetta) Dulaglutide (Trulicity) Liraglutide (Saxenda, Victoza) These medications offer a range of options for individuals seeking alternatives to semaglutide, ensuring flexibility in obesity and diabetes management based on personal preferences and healthcare provider recommendations
The most common side effects remain mild and manageable: gastrointestinal symptoms (nausea, vomiting, diarrhea) from tirzepatide and potential metformin-related gastrointestinal upset are usually mild when tirzepatide is started at low doses and titrated gradually
Here are the most common ones to look out for: Nausea Vomiting Diarrhea Constipation Abdominal Pain Headache Fatigue Serious side effects largely mirror those of Zepbound, including risks of low blood sugar, pancreatitis, gallbladder issues, kidney problems, allergic reactions, and mood changes
Understanding when to seek medical guidance helps prevent complications and optimizes therapeutic outcomes
For those using tirzepatide primarily for weight management, discussion will focus on sustainable lifestyle strategies and whether other interventions might be appropriate
